;PMID: 6836571
;source_file_833.mrg
;Release 0.9 of PennBioIE
;Funded by NSF ITR EIA-0205448

;0)section:[e:0..46] = [t:0..46]
;1)sentence:[e:52..159] = [t:52..159]
;2)section:[e:163..206] = [t:163..206]
;3)sentence:[e:210..331] = [t:210..331]
;4)sentence:[e:332..596] = [t:332..596]
;5)sentence:[e:597..720] = [t:597..720]
;6)sentence:[e:721..1054] = [t:721..1054]
;7)sentence:[e:1055..1165] = [t:1055..1165]
;8)sentence:[e:1166..1323] = [t:1166..1323]
;9)sentence:[e:1324..1454] = [t:1324..1454]
;10)sentence:[e:1455..1734] = [t:1455..1734]
;11)section:[e:1738..1782] = [t:1738..1782]

;section 0 Span:0..46
;Toxicol Appl Pharmacol. 1983 Feb;67(2):159-65.
(SEC
  (FRAG (NNP:[0..7] Toxicol) (NNP:[8..12] Appl) (NNP:[13..22] Pharmacol)
        (.:[22..23] .) (CD:[24..28] 1983) (CC:[29..36] Feb;67-LRB-)
        (CD:[36..37] 2) (-RRB-:[37..38] -RRB-) (CD:[38..42] :159)
        (NN:[42..43] -) (CD:[43..45] 65) (.:[45..46] .)))

;sentence 1 Span:52..159
;Time course of the carbon tetrachloride-induced decrease in mitochondrial 
;aldehyde dehydrogenase activity.
;[71..91]:substance:"carbon tetrachloride"
;[127..149]:substance:"aldehyde dehydrogenase"
(SENT
  (NP-HLN
    (NP (NN:[52..56] Time) (NN:[57..63] course))
    (PP (IN:[64..66] of)
      (NP
        (NP (DT:[67..70] the)
          (ADJP
            (NML (NN:[71..77] carbon) (NN:[78..91] tetrachloride))
            (HYPH:[91..92] -) (VBN:[92..99] induced))
          (NN:[100..108] decrease))
        (PP (IN:[109..111] in)
          (NP (JJ:[112..125] mitochondrial)
            (NML (NN:[127..135] aldehyde) (NN:[136..149] dehydrogenase))
            (NN:[150..158] activity)))))
    (.:[158..159] .)))

;section 2 Span:163..206
;Hjelle JJ, Grubbs JH, Beer DG, Petersen DR.
(SEC
  (FRAG (NNP:[163..169] Hjelle) (NNP:[170..172] JJ) (,:[172..173] ,)
        (NNP:[174..180] Grubbs) (NNP:[181..183] JH) (,:[183..184] ,)
        (NNP:[185..189] Beer) (NNP:[190..192] DG) (,:[192..193] ,)
        (NNP:[194..202] Petersen) (NNP:[203..206] DR.)))

;sentence 3 Span:210..331
;Hepatic microsomal enzymes like cytochrome P-450 and glucose 6-phosphatase
;are  inhibited after exposure to CCl4 in vivo.
;[229..236]:substance:"enzymes"
;[242..258]:cyp450:"cytochrome P-450"
;[263..284]:substance:"glucose 6-phosphatase"
;[318..322]:substance:"CCl4"
(SENT
  (S
    (NP-SBJ-1
      (NP (JJ:[210..217] Hepatic) (JJ:[218..228] microsomal)
          (NNS:[229..236] enzymes))
      (PP (IN:[237..241] like)
        (NP
          (NP (NN:[242..252] cytochrome) (NN:[253..258] P-450))
          (CD:[259..262] and)
          (NP (NN:[263..270] glucose) (NN:[271..284] 6-phosphatase)))))
    (VP (VBP:[285..288] are)
      (VP (JJ:[290..299] inhibited)
        (NP-1 (-NONE-:[299..299] *))
        (PP-TMP (IN:[300..305] after)
          (NP
            (NP (NN:[306..314] exposure))
            (PP (TO:[315..317] to)
              (NP (NN:[318..322] CCl4)))))
        (ADVP (FW:[323..325] in) (FW:[326..330] vivo))))
    (.:[330..331] .)))

;sentence 4 Span:332..596
;Since comparatively less is known  about the effects of CCl4 on nonmicrosomal
;enzymes, we investigated the rapidity  by which CCl4 inhibits the low Km
;mitochondrial aldehyde dehydrogenase (ALDH)  isozyme, an enzyme known to be
;inhibited 24 hr after CCl4 treatment.
;[388..392]:substance:"CCl4"
;[410..417]:substance:"enzymes"
;[458..462]:substance:"CCl4"
;[480..482]:quantitative-name:"Km"
;[497..535]:substance:"aldehyde dehydrogenase (ALDH)  isozyme"
;[540..546]:substance:"enzyme"
;[569..571]:quantitative-value:"24"
;[572..574]:quantitative-units:"hr"
;[581..585]:substance:"CCl4"
(SENT
  (S
    (SBAR-ADV (IN:[332..337] Since)
      (S
        (NP-SBJ (RB:[338..351] comparatively) (JJR:[352..356] less))
        (VP (VBZ:[357..359] is)
          (ADJP-PRD (JJ:[360..365] known)
            (PP (IN:[367..372] about)
              (NP
                (NP (DT:[373..376] the) (NNS:[377..384] effects))
                (PP (IN:[385..387] of)
                  (NP (NN:[388..392] CCl4)))
                (PP (IN:[393..395] on)
                  (NP (JJ:[396..409] nonmicrosomal) (NNS:[410..417] enzymes)))))))))
    (,:[417..418] ,)
    (NP-SBJ (PRP:[419..421] we))
    (VP (VBD:[422..434] investigated)
      (NP
        (NP (DT:[435..438] the) (NN:[439..447] rapidity))
        (SBAR
          (WHPP-1 (IN:[449..451] by)
            (WHNP (WDT:[452..457] which)))
          (S
            (NP-SBJ (NN:[458..462] CCl4))
            (VP (VBZ:[463..471] inhibits)
              (NP
                (NP (DT:[472..475] the)
                  (NML (JJ:[476..479] low) (NN:[480..482] Km))
                  (JJ:[483..496] mitochondrial)
                  
                  (NML
                    (NML (NN:[497..505] aldehyde) (NN:[506..519] dehydrogenase))
                    (NML (-LRB-:[520..521] -LRB-) (NN:[521..525] ALDH)
                         (-RRB-:[525..526] -RRB-)))
                  (NN:[528..535] isozyme))
                (,:[535..536] ,)
                (NP
                  (NP (DT:[537..539] an) (NN:[540..546] enzyme))
                  (VP (JJ:[547..552] known)
                    (S
                      (NP-SBJ-2 (-NONE-:[552..552] *))
                      (VP (TO:[553..555] to)
                        (VP (VB:[556..558] be)
                          (VP (JJ:[559..568] inhibited)
                            (NP-2 (-NONE-:[568..568] *))
                            (PP-TMP
                              (NP-ADV (CD:[569..571] 24) (NNS:[572..574] hr))
                              (IN:[575..580] after)
                              (NP (NN:[581..585] CCl4) (NN:[586..595] treatment))))))))))
              (PP-1 (-NONE-:[595..595] *T*)))))))
    (.:[595..596] .)))

;sentence 5 Span:597..720
;The  activity of this ALDH isozyme was significantly lowered 6 and 12 hr
;after a  single 1 ml/kg intragastric dose of CCl4.
;[619..631]:substance:"ALDH isozyme"
;[658..659]:quantitative-value:"6"
;[664..666]:quantitative-value:"12"
;[667..669]:quantitative-units:"hr"
;[686..687]:quantitative-value:"1"
;[688..693]:quantitative-units:"ml/kg"
;[715..719]:substance:"CCl4"
(SENT
  (S
    (NP-SBJ-2
      (NP (DT:[597..600] The) (NN:[602..610] activity))
      (PP (IN:[611..613] of)
        (NP (DT:[614..618] this)
           (NN:[619..623] ALDH) (NN:[624..631] isozyme))))
    (VP (VBD:[632..635] was)
      (ADVP (RB:[636..649] significantly))
      (VP (VBN:[650..657] lowered)
        (NP-2 (-NONE-:[657..657] *))
        (PP
          (NP-ADV
            (NP (CD:[658..659] 6)
              (NML-1 (-NONE-:[659..659] *P*)))
            (CC:[660..663] and)
            (NP (CD:[664..666] 12)
              (NML-1 (NNS:[667..669] hr))))
          (IN:[670..675] after)
          (NP
            (NP (DT:[676..677] a) (JJ:[679..685] single)
              (NML
                (NML (CD:[686..687] 1) (NN:[688..690] ml))
                (PP (SYM:[690..691] /)
                  (NP (NN:[691..693] kg))))
              (JJ:[694..706] intragastric) (NN:[707..711] dose))
            (PP (IN:[712..714] of)
              (NP (NN:[715..719] CCl4)))))))
    (.:[719..720] .)))

;sentence 6 Span:721..1054
;The mitochondrial low Km ALDH specific  activities exhibited a similar
;pattern of destruction/inhibition to the  documented target enzyme microsomal
;cytochrome P-450 in that lowest values were  observed 6 hr after CCl4. These
;values were 44 and 37% of control for cytochrome  P-450 content and the low
;Km ALDH activity, respectively.
;[743..745]:quantitative-name:"Km"
;[746..750]:substance:"ALDH"
;[852..858]:substance:"enzyme"
;[870..886]:cyp450:"cytochrome P-450"
;[924..925]:quantitative-value:"6"
;[926..928]:quantitative-units:"hr"
;[935..939]:substance:"CCl4"
;[959..961]...[968..969]:quantitative-value:"44"..."%"
;[966..969]:quantitative-value:"37%"
;[985..1002]:cyp450:"cytochrome  P-450"
;[1023..1025]:quantitative-name:"Km"
;[1026..1030]:substance:"ALDH"
(SENT
  (S
    (NP-SBJ (DT:[721..724] The) (JJ:[725..738] mitochondrial)
      (NML (JJ:[739..742] low) (NN:[743..745] Km))
      (ADJP (NN:[746..750] ALDH) (JJ:[751..759] specific))
      (NNS:[761..771] activities))
    (VP (VBD:[772..781] exhibited)
      (NP
        (NP (DT:[782..783] a) (JJ:[784..791] similar) (NN:[792..799] pattern))
        (PP (IN:[800..802] of)
          (NP (NN:[803..814] destruction) (SYM:[814..815] /)
              (NN:[815..825] inhibition)))
        (PP (TO:[826..828] to)
          (NP
            (NP (DT:[829..832] the) (VBN:[834..844] documented)
                (NN:[845..851] target) (NN:[852..858] enzyme))
            (NP (JJ:[859..869] microsomal)
               (NN:[870..880] cytochrome) (NN:[881..886] P-450)))))
      (SBAR-ADV (IN:[887..889] in) (IN:[890..894] that)
        (S
          (NP-SBJ-1 (JJS:[895..901] lowest) (NNS:[902..908] values))
          (VP (VBD:[909..913] were)
            (VP (VBN:[915..923] observed)
              (NP-1 (-NONE-:[923..923] *))
              (PP-TMP
                (NP-ADV (CD:[924..925] 6) (NNS:[926..928] hr))
                (IN:[929..934] after)
                (NP (NN:[935..939] CCl4))))))))
    (.:[939..940] .))
  (S
    (NP-SBJ (DT:[941..946] These) (NNS:[947..953] values))
    (VP (VBD:[954..958] were)
      (NP-PRD
        (NP
          (NP (CD:[959..961] 44)
            (NML-2 (-NONE-:[961..961] *P*)))
          (CC:[962..965] and)
          (NP (CD:[966..968] 37)
            (NML-2 (NN:[968..969] %))))
        (PP (IN:[970..972] of)
          (NP (NN:[973..980] control))))
      (PP (IN:[981..984] for)
        (NP
          (NP
            (NML (NN:[985..995] cytochrome) (NN:[997..1002] P-450))
            (NN:[1003..1010] content))
          (CC:[1011..1014] and)
          (NP (DT:[1015..1018] the)
            (NML (JJ:[1019..1022] low) (NN:[1023..1025] Km))
            (NN:[1026..1030] ALDH) (NN:[1031..1039] activity))))
      (,:[1039..1040] ,)
      (ADVP (RB:[1041..1053] respectively)))
    (.:[1053..1054] .)))
;ERROR_Sentence has multiple Children (Sentence Error)[721..1054]::S:S:

;sentence 7 Span:1055..1165
;Alcohol dehydrogenase  activity, expressed as activity per gram liver, was
;depressed 12 hr after CCl4  dosing.
;[1055..1076]:substance:"Alcohol dehydrogenase"
;[1101..1124]:quantitative-units:"activity per gram liver"
;[1140..1142]:quantitative-value:"12"
;[1143..1145]:quantitative-units:"hr"
;[1152..1156]:substance:"CCl4"
(SENT
  (S
    (NP-SBJ-1
      (NP
        (NML (NN:[1055..1062] Alcohol) (NN:[1063..1076] dehydrogenase))
        (NN:[1078..1086] activity))
      (,:[1086..1087] ,)
      (VP (VBN:[1088..1097] expressed)
        (NP (-NONE-:[1097..1097] *))
        (PP-CLR (IN:[1098..1100] as)
          (NP
            (NP (NN:[1101..1109] activity))
            (PP (IN:[1110..1113] per)
              (NP (NN:[1114..1118] gram) (NN:[1119..1124] liver))))))
      (,:[1124..1125] ,))
    (VP (VBD:[1126..1129] was)
      (VP (VBN:[1130..1139] depressed)
        (NP-1 (-NONE-:[1139..1139] *))
        (PP-TMP
          (NP-ADV (CD:[1140..1142] 12) (NNS:[1143..1145] hr))
          (IN:[1146..1151] after)
          (NP (NN:[1152..1156] CCl4) (NN:[1158..1164] dosing)))))
    (.:[1164..1165] .)))

;sentence 8 Span:1166..1323
;Finally, the activity of the low Km cytosolic ALDH, the isozyme that 
;metabolizes malondialdehyde at low concentrations, was not affected by CCl4 
;treatment.
;[1199..1201]:quantitative-name:"Km"
;[1212..1216]:substance:"ALDH"
;[1222..1229]:substance:"isozyme"
;[1248..1263]:substance:"malondialdehyde"
;[1307..1311]:substance:"CCl4"
(SENT
  (S
    (ADVP (RB:[1166..1173] Finally))
    (,:[1173..1174] ,)
    (NP-SBJ-2
      (NP (DT:[1175..1178] the) (NN:[1179..1187] activity))
      (PP (IN:[1188..1190] of)
        (NP
          (NP (DT:[1191..1194] the)
            (NML (JJ:[1195..1198] low) (NN:[1199..1201] Km))
            (JJ:[1202..1211] cytosolic) (NN:[1212..1216] ALDH))
          (,:[1216..1217] ,)
          (NP
            (NP (DT:[1218..1221] the) (NN:[1222..1229] isozyme))
            (SBAR
              (WHNP-1 (WDT:[1230..1234] that))
              (S
                (NP-SBJ-1 (-NONE-:[1234..1234] *T*))
                (VP (VBZ:[1236..1247] metabolizes)
                  (NP (NN:[1248..1263] malondialdehyde))
                  (PP (IN:[1264..1266] at)
                    (NP (JJ:[1267..1270] low) (NN:[1271..1285] concentrations))))))))))
    (,:[1285..1286] ,)
    (VP (VBD:[1287..1290] was) (RB:[1291..1294] not)
      (VP (VBN:[1295..1303] affected)
        (NP-2 (-NONE-:[1303..1303] *))
        (PP (IN:[1304..1306] by)
          (NP-LGS (NN:[1307..1311] CCl4) (NN:[1313..1322] treatment)))))
    (.:[1322..1323] .)))

;sentence 9 Span:1324..1454
;The CCl4-induced decline in the activity of the matrix ALDH isozyme  occurs
;earlier than previously reported mitochondrial damage.
;[1328..1332]:substance:"CCl4"
;[1379..1391]:substance:"ALDH isozyme"
(SENT
  (S
    (NP-SBJ
      (NP (DT:[1324..1327] The)
        (ADJP (NN:[1328..1332] CCl4) (HYPH:[1332..1333] -)
              (VBN:[1333..1340] induced))
        (NN:[1341..1348] decline))
      (PP (IN:[1349..1351] in)
        (NP
          (NP (DT:[1352..1355] the) (NN:[1356..1364] activity))
          (PP (IN:[1365..1367] of)
            (NP (DT:[1368..1371] the)
              (NML (NN:[1372..1378] matrix) (NN:[1379..1383] ALDH))
              (NN:[1384..1391] isozyme))))))
    (VP (VBZ:[1393..1399] occurs)
      (ADVP (JJR:[1400..1407] earlier)
        (PP (IN:[1408..1412] than)
          (NP
            (ADJP (RB:[1413..1423] previously) (VBN:[1424..1432] reported))
            (JJ:[1433..1446] mitochondrial) (NN:[1447..1453] damage)))))
    (.:[1453..1454] .)))

;sentence 10 Span:1455..1734
;The study of  sensitive enzymes like the low Km ALDH may provide valuable
;information by which  it may be possible to determine the relationship of the
;truly rapid biochemical  effects of CCl4 such as microsomal lipid
;peroxidation with later effects on  nonmicrosomal components.
;[1479..1486]:substance:"enzymes"
;[1500..1502]:quantitative-name:"Km"
;[1503..1507]:substance:"ALDH"
;[1643..1647]:substance:"CCl4"
(SENT
  (S
    (NP-SBJ
      (NP (DT:[1455..1458] The) (NN:[1459..1464] study))
      (PP (IN:[1465..1467] of)
        (NP
          (NP (JJ:[1469..1478] sensitive) (NNS:[1479..1486] enzymes))
          (PP (IN:[1487..1491] like)
            (NP (DT:[1492..1495] the)
              (NML (JJ:[1496..1499] low) (NN:[1500..1502] Km))
              (NN:[1503..1507] ALDH))))))
    (VP (MD:[1508..1511] may)
      (VP (VB:[1512..1519] provide)
        (NP
          (NP (JJ:[1520..1528] valuable) (NN:[1529..1540] information))
          (SBAR
            (WHPP-1 (IN:[1541..1543] by)
              (WHNP (WDT:[1544..1549] which)))
            (S
              (NP-SBJ (PRP:[1551..1553] it))
              (VP (MD:[1554..1557] may)
                (VP (VB:[1558..1560] be)
                  (ADJP-PRD (JJ:[1561..1569] possible)
                    (S
                      (NP-SBJ (-NONE-:[1569..1569] *))
                      (VP (TO:[1570..1572] to)
                        (VP (VB:[1573..1582] determine)
                          (NP
                            (NP (DT:[1583..1586] the)
                                (NN:[1587..1599] relationship))
                            (PP (IN:[1600..1602] of)
                              (NP
                                (NP
                                  (NP (DT:[1603..1606] the)
                                    (ADJP (RB:[1607..1612] truly)
                                          (JJ:[1613..1618] rapid))
                                    (JJ:[1619..1630] biochemical)
                                     (NNS:[1632..1639] effects))
                                  (PP (IN:[1640..1642] of)
                                    (NP (NN:[1643..1647] CCl4))))
                                (PP (JJ:[1648..1652] such) (IN:[1653..1655] as)
                                  (NP (JJ:[1656..1666] microsomal)
                                      (NN:[1667..1672] lipid)
                                      (NN:[1673..1685] peroxidation)))))
                            (PP (IN:[1686..1690] with)
                              (NP
                                (NP (JJ:[1691..1696] later)
                                    (NNS:[1697..1704] effects))
                                (PP (IN:[1705..1707] on)
                                  (NP (JJ:[1709..1722] nonmicrosomal)
                                      (NNS:[1723..1733] components))))))
                          (PP-1 (-NONE-:[1733..1733] *T*)))))))))))))
    (.:[1733..1734] .)))

;section 11 Span:1738..1782
;PMID: 6836571 [PubMed - indexed for MEDLINE]
(SEC
  (FRAG (NNP:[1738..1742] PMID) (::[1742..1743] :) (CD:[1744..1751] 6836571)
        (-LRB-:[1752..1753] -LSB-) (NNP:[1753..1759] PubMed)
        (HYPH:[1760..1761] -) (NN:[1762..1769] indexed) (IN:[1770..1773] for)
        (NNP:[1774..1781] MEDLINE) (-RRB-:[1781..1782] -RSB-)))
